Form D · Biotechnology
Tropogenix, Inc.
San Antonio, TX · CIK 0002086858
Offering snapshot reported Sep 30, 2025 · SEC filing
- Reported sold
- $250K Offering amount: $2.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 26, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 30, 2025 | Amendment | $250,000 | $0vs Sep 22, 2025 | 1 | SEC filing |
| Sep 22, 2025 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-558278
Source: Form D, filed Sep 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Castella | Director, Executive |
| Bryan Daniels | Director |
| Kevin Meehan | Director |
| Kristen Parker | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:San Antonio, TX, 78249